Related Experiment Video
Updated: Jun 23, 2026

Analyzing Protein Dynamics Using Hydrogen Exchange Mass Spectrometry
Published on: November 29, 2013
Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent
C E Stebbins1, A A Russo, C Schneider
1Department of Biochemistry and Structural Biology, Cornell University Graduate School of Medical Sciences, New York, New York 10021, USA.
Abstract:
The Hsp90 chaperone is required for the activation of several families of eukaryotic protein kinases and nuclear hormone receptors, many of which are protooncogenic and play a prominent role in cancer. The geldanamycin antibiotic has antiproliferative and antitumor effects, as it binds to Hsp90, inhibits the Hsp90-mediated conformational maturation/refolding reaction, and results in the degradation of Hsp90 substrates. The structure of the geldanamycin-binding domain of Hsp90 (residues 9-232) reveals a pronounced pocket, 15 A deep, that is highly conserved across species. Geldanamycin binds inside this pocket, adopting a compact structure similar to that of a polypeptide chain in a turn conformation. This, and the pocket's similarity to substrate-binding sites, suggest that the pocket binds a portion of the polypeptide substrate and participates in the conformational maturation/refolding reaction.
Insights
Geldanamycin, an antibiotic targeting heat shock protein 90 (Hsp90), inhibits cancer-promoting protein activation. Structural analysis reveals Hsp90
Area of Science:
- Molecular Biology
- Structural Biology
- Oncology
Background:
- Heat shock protein 90 (Hsp90) is crucial for activating eukaryotic protein kinases and nuclear hormone receptors, many implicated in cancer.
- Protooncogenic proteins often rely on Hsp90 for their function and stability.
- Inhibiting Hsp90 can lead to the degradation of these cancer-promoting substrates.
Purpose of the Study:
- To elucidate the structural basis of Hsp90 inhibition by geldanamycin.
- To understand how geldanamycin binding affects Hsp90's conformational maturation function.
- To explore the implications for cancer therapy.
Main Methods:
- X-ray crystallography to determine the structure of the geldanamycin-binding domain of Hsp90.
- Biochemical assays to study Hsp90-mediated conformational maturation.
- Analysis of conserved structural features within the Hsp90 binding pocket.
Main Results:
- The structure of the Hsp90-geldanamycin complex revealed a deep, conserved binding pocket.
- Geldanamycin adopts a compact, turn-like conformation within this pocket.
- The pocket's structure suggests it interacts with Hsp90 substrates, participating in conformational maturation.
Conclusions:
- Geldanamycin inhibits Hsp90 by binding to a conserved pocket, interfering with substrate conformational maturation.
- This mechanism underlies geldanamycin's antiproliferative and antitumor effects.
- The Hsp90 binding pocket is a potential target for developing novel cancer therapeutics.
Related Concept Videos
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Molecular Chaperones and Protein Folding
The...
Export of Misfolded Proteins out of the ER
Molecular Chaperones and Protein Folding
The...

